share_log

PainReform | 6-K: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K: Report of foreign private issuer (related to financial reporting)

PainReform | 6-K：外國發行人報告（業績相關）
美股SEC公告 ·  2024/10/16 10:38

Moomoo AI 已提取核心訊息

PainReform Ltd. has entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC on October 16, 2024. The agreement allows PainReform to offer and sell ordinary shares with an aggregate offering price of up to $1.35 million. The shares will be sold through Wainwright as the sales agent in "at-the-market" offerings.The offering will be made under a shelf registration statement on Form F-3 filed with the SEC. Wainwright will receive a 3.0% commission on gross sales and be provided with customary indemnification rights. The agreement includes standard representations, warranties, and conditions for the sale of shares.The offering will terminate upon the earliest of agreement termination by either party or mutual agreement. This move provides PainReform with a flexible mechanism to raise capital as needed, potentially strengthening its financial position for future operations and development.
PainReform Ltd. has entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC on October 16, 2024. The agreement allows PainReform to offer and sell ordinary shares with an aggregate offering price of up to $1.35 million. The shares will be sold through Wainwright as the sales agent in "at-the-market" offerings.The offering will be made under a shelf registration statement on Form F-3 filed with the SEC. Wainwright will receive a 3.0% commission on gross sales and be provided with customary indemnification rights. The agreement includes standard representations, warranties, and conditions for the sale of shares.The offering will terminate upon the earliest of agreement termination by either party or mutual agreement. This move provides PainReform with a flexible mechanism to raise capital as needed, potentially strengthening its financial position for future operations and development.
PainReform有限公司於2024年10月16日與H.C. Wainwright & Co., LLC簽署了一項市場發售協議。該協議允許PainReform以最多135萬美元的總髮行價提供和出售普通股。這些股份將通過Wainwright作爲銷售代理按照「市場發售」的方式進行出售。該發行將依據提交給SEC的F-3表格的貨架註冊聲明進行。Wainwright將獲得銷售總額3.0%的佣金，並被提供通常的賠償權利。該協議包括股份出售的標準陳述、保證和條件。該發行將在任何一方終止協議或雙方達成共識時最早終止。這一舉措爲PainReform提供了靈活的資本籌集機制，根據需要籌集資金，可能增強其未來運營和發展的財務狀況。
PainReform有限公司於2024年10月16日與H.C. Wainwright & Co., LLC簽署了一項市場發售協議。該協議允許PainReform以最多135萬美元的總髮行價提供和出售普通股。這些股份將通過Wainwright作爲銷售代理按照「市場發售」的方式進行出售。該發行將依據提交給SEC的F-3表格的貨架註冊聲明進行。Wainwright將獲得銷售總額3.0%的佣金，並被提供通常的賠償權利。該協議包括股份出售的標準陳述、保證和條件。該發行將在任何一方終止協議或雙方達成共識時最早終止。這一舉措爲PainReform提供了靈活的資本籌集機制，根據需要籌集資金，可能增強其未來運營和發展的財務狀況。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間